The role of Acinetobacter in the pathogenesis of multiple sclerosis examined by using Popper sequences

Medical Hypotheses

Volumn 78, Issue 6, 2012, Pages 763-769

  Ebringer, Alan ^a   Rashid, Taha ^a   Wilson, Clyde ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b King Edward VII Memorial Hospital   (Bermuda)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; METHOTREXATE; MITOXANTRONE; MYELIN; MYELIN BASIC PROTEIN; NATALIZUMAB; RECOMBINANT INTERFERON;

ACINETOBACTER; ALLERGIC ENCEPHALOMYELITIS; ANALYTIC METHOD; ARTICLE; CLIMATE; COLD EXPOSURE; DISEASE COURSE; ESCHERICHIA COLI; FAMILY; GENETIC ASSOCIATION; HUMAN; LATITUDE; MIGRATION; MONOZYGOTIC TWINS; MULTIPLE SCLEROSIS; NONHUMAN; PARANASAL SINUS; PATHOGENESIS; POPPER SEQUENCE; PSEUDOMONAS AERUGINOSA; SINUSITIS; STATISTICAL SIGNIFICANCE;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTIBODIES, BACTERIAL; DEMOGRAPHY; GEOGRAPHY; HUMANS; IMMUNOGLOBULIN A; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; MYELIN SHEATH; PARANASAL SINUSES; SINUSITIS;

ACINETOBACTER; ANIMALIA; BOVINAE;

EID: 84860381154     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.02.026     Document Type: Article

References (36)

1. Compston A. Multiple sclerosis and other demyelinating diseases. Brain's diseases of the nervous system 2009, 1131-1177. Oxford University Press, Oxford. M. Donaghy (Ed.).
2. Riley C.S., Tullman M.J. Demyelinating diseases: multiple sclerosis. Merritt's neurology 2010, 903-918. Lippincott, Philadelphia. L.P. Rowland, T.A. Pedley (Eds.).
3. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517. [PubMed: 18970977].
4. Greer J.M., McCombe P.A. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol 2011, 234:7-18. [PubMed: 21474189].
5. Ebringer A., Rashid T., Wilson C. Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper. Autoimmun Rev 2010, 9:216-223. [PubMed: 19895906].
6. Popper K.R. Truth, rationality and the growth of scientific knowledge. Conjectures and refutations 1969, 215-250. Taylor & Francis Ltd. Routledge, London. K.R. Popper (Ed.).
7. Deretzi G., Kountouras J., Koutlas E., Zavos C., Polyzos S., Rudolf J., et al. Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece. Mult Scler 2010, 16:1091-1101. [PubMed: 20639270].
8. Sadovnick A.D., Armstrong H., Rice G.P., Bulman D., Hashimoto L., Paty D.W., et al. A population-based study of multiple sclerosis in twins: update. Ann Neurol 1993, 33:281-285. [PubMed: 8498811].
9. Hafler D.A., Compston A., Saweer S., Lander E.S., Daly M.J., De Jager P.L., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007, 357:851-862. [PubMed: 17660530].
10. Chao M.J., Ramagopalan S.V., Herrera B.M., Orton S.M., Handunnetthi L., Lincoln M.R., et al. MHC transmission: insights into gender bias in MS susceptibility. Neurology 2011, 76:242-246. [PubMed: 21209377].
11. Hoffjan S., Akkad D.A. The genetics of multiple sclerosis: an update 2010. Mol Cell Probes 2010, 24:237-243. [PubMed: 20450971].
12. Simpson S., Blizzard L., Otahal P., Van der Mei I., Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011, 82:1132-1141. [PubMed: 21478203].
13. Krokki O., Bloigu R., Reunanen M., Remes A.M. Increasing incidence of multiple sclerosis in women in Northern Finland. Mult Scler 2011, 17:133-138. [PubMed: 20935028].
14. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001, 22:117-139. [PubMed: 11603614].
15. Honan W.P., Heron J.R., Foster D.H., Snelgar R.S. Paradoxical effects of temperature in multiple sclerosis. J Neurol Neurosurg Psychiatry 1987, 50:1160-1164. [PubMed: 3668565].
16. Michael J.A., Davis F.A. Effects of induced hyperthermia in multiple sclerosis: differences in visual acuity during heating and recovery phases. Acta Neurol Scand 1973, 49:141-151. [PubMed: 4718187].
17. Kurtzke J.F., Delasnerie-Lauprêtre N., Wallin M.T. Multiple sclerosis in North African migrants to France. Acta Neurol Scand 1998, 98:302-309. [PubMed: 98588098].
18. Hammond S.R., English D.R., McLeod J.G. The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain 2000, 123:968-974. [PubMed: 10775541].
19. Casiano R.R., Cohn S., Villasuso E., Brown M., Memari F., Barquist E. Comparison of antral tap with endoscopically directed nasal culture. Laryngoscope 2001, 111:1333-1337. [PubMed: 11568565].
20. Yavankar S.P., Pardesi K.R., Chopade B.A. Species distribution and physiological characterization of Acinetobacter genospecies from healthy human skin of tribal population in India. Indian J Med Microbiol 2007, 25:336-345. [PubMed: 18087081].
21. Miller D.H., Hammond S.R., McLeod J.G., Purdie G., Skegg D.C. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental. J Neurol Neurosurg Psychiatry 1990, 53:903-905. [PubMed: 2266373].
22. Handel A.E., Williamson A.J., Disanto G., Dobson R., Giovannoni G., Ramagopalan S.V. Smoking and multiple sclerosis: an updated meta-analysis. PLoS One 2011, 6:e16149. [PubMed: 21249154].
23. Pessey J.J., Reitz C., Los F. Acute rhinosinusitis in adults: national survey of general practice management. Rev Laryngol Otol Rhinol 2000, 121:237-241. [PubMed: 11233706].
24. Gay D., Dick G., Upton G. Multiple sclerosis associated with sinusitis: case-controlled study in general practice. Lancet 1986, 1(8485):815-819. [PubMed: 2870312].
25. Jones R.L., Crowe P., Chavda S.V., Pahor A.L. The incidence of sinusitis in patients with multiple sclerosis. Rhinology 1997, 35:118-119. [PubMed: 9403941].
26. Jones R.L., Crowe P., Chavda S.V., Pahor A.L. Multiple sclerosis and sinusitis. Lancet 1986, 2(8499):160-161.
27. Pearce J.M. Louis Pasteur and rabies: a brief note. J Neurol Neurosurg Psychiatry 2002, 73:82. [PubMed: 12082056].
28. Westonhurst E. The effects of the injection of normal brain emulsion into rabbit with specific reference to the aetiology of the paralytic accidents of the anti-rabic treatment. J Hyg 1932, 32:33-44.
29. Ebringer A., Hughes L., Rashid T., Wilson C. Acinetobacter immune responses in multiple sclerosis: etiopathogenetic role and its possible use as a diagnostic marker. Arch Neurol 2005, 62:33-36. [PubMed: 15642847].
30. Ebringer A., Rashid T., Jawad N., Wilson C., Thompson E.J., Ettelaie C. From rabies to transmissible spongiform encephalopathies: an immune mediated microbial trigger involving molecular mimicry could be the answer. Med Hypotheses 2007, 68:113-124. [PubMed: 16920276].
31. Hughes L.E., Bonell S., Natt R.S., Wilson C., Tiwana H., Ebringer A., et al. Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin - Acinetobacter - neurofilament antibody index. Clin Diagn Lab Immunol 2001, 8:1181-1188. [PubMed: 11687461].
32. Lee J.C., Koerten H., van den Broek P., Beekhulzen H., Wolterbeek R., van den Barselaar M., et al. Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol 2006, 157:360-366. [PubMed: 16326077].
33. Zhang Y., Da R.R., Hilgenberg L.G., Tourtellotte W.W., Sobel R.A., Smith M.A., et al. Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions. J Neuroimmunol 2005, 167:120-130. [PubMed: 16099056].
34. Hughes L., Smith P.A., Bonell S., Natt R.S., Wilson C., Rashid T., et al. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. J Neuroimmunol 2003, 144:105-115. [PubMed: 14597104].
35. Rio J., Comabella M., Montalban X. Multiple sclerosis: current treatment algorithms. Curr Opin Neurol 2011, 24:230-237. [PubMed: 21499098].
36. Putzki N., Yaldizli O., Buhler R., Schwegler G., Curtius D., Tettenborn B. Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: results from a multicenter study in Switzerland. Eur Neurol 2010, 63:101-106. [PubMed: 20090344].